Novel findings on GRB2 and SOS1 could pave the way for cancer treatments

This post was originally published on News-medical.net

You will shortly be re-directed to the publisher's website

Researchers from Tokyo Metropolitan University have uncovered new insights into how the proteins GRB2 and SOS1 in cells pass signals from membrane receptors to nuclei.